drugset / Trial / NCT00324610
Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen
Phase 1/2
Unknown
46 enrolled
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Summary
Standard administration of capecitabine use a 14 days administration. Routine practice in several intitution leads to use a 5 out of 7 days regimen, with less toxicity. Purpose : to compare the pharmacokinetics of capecitabine, administered 5 days out of 7, as compared to the standard administration (14 days out of 21). The second end point is to compare toxicity with either regimen. Method : Randomized study with two groups : one with standard administration , the second with 5/7 days regimen
Timeline
- Start
- 2006-03
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | — | — |